Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01)

The summary for the Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01): -Purpose. Through this program announcement with set aside (PAS), the National Institute on Drug Abuse (NIDA) invites applicants to develop innovative drug abuse epidemiology or health services research in cooperation with academic centers supported through the NIH Clinical and Translational Science Awards (CTSA) consortium. A major NIH initiative, the CTSA consortium is transforming how clinical and translational research is conducted, building an infrastructure for multidisciplinary researchers and clinicians to perform research and develop new treatments more efficiently. As a part of this infrastructure, CTSA sites have established partnerships with a range of clinical settings and have access to large, multi-generational population cohorts. These features of the CTSA sites offer a unique opportunity for researchers to integrate drug abuse epidemiology and health services research in these settings. Applicants are asked to propose innovative drug abuse research which builds upon the resources available at CTSA sites, resources which would include CTSA efforts to strengthen networks of clinical sites and to establish innovative information technologies, phenotyping systems, and biobanks. A broad range of drug abuse epidemiology and health services research areas will be supported under the auspices of this FOA, as described below. -Mechanism of Support. This FOA will utilize the R01 grant mechanism. -Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 4 to 8 projects awarded as a result of this announcement is $2 million for fiscal year 2009 and $2 million for fiscal year 2010. Future year amounts will depend on annual appropriations. The total amount awarded and the number of awards will depend upon the number, quality, duration, and cost of the applications received. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.